Drugs / BMS-59926
last change Apr 2006 re-read 3 minutes ago

BMS-59926

Developed for
cancer of unknown primary site
Investigated by
Jonsson Comprehensive Cancer Center · National Cancer Institute (NCI)

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00093730 Aug 2004 → Apr 2006 cancer of unknown primary site Jonsson Comprehensive Cancer Center Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BMS-59926 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00093730 ↗